GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NKGen Biotech Inc (NAS:NKGN) » Definitions » ROE % Adjusted to Book Value

NKGen Biotech (NKGen Biotech) ROE % Adjusted to Book Value : 0.00% (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is NKGen Biotech ROE % Adjusted to Book Value?

NKGen Biotech's ROE % for the quarter that ended in Mar. 2024 was 0.00%. NKGen Biotech's PB Ratio for the quarter that ended in Mar. 2024 was N/A. NKGen Biotech's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was N/A.

NKGen Biotech ROE % Adjusted to Book Value Historical Data

The historical data trend for NKGen Biotech's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NKGen Biotech ROE % Adjusted to Book Value Chart

NKGen Biotech Annual Data
Trend Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
- - -

NKGen Biotech Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
ROE % Adjusted to Book Value Get a 7-Day Free Trial - - - - -

Competitive Comparison of NKGen Biotech's ROE % Adjusted to Book Value

For the Biotechnology subindustry, NKGen Biotech's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NKGen Biotech's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NKGen Biotech's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where NKGen Biotech's ROE % Adjusted to Book Value falls into.


NKGen Biotech ROE % Adjusted to Book Value Calculation

NKGen Biotech's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

NKGen Biotech's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NKGen Biotech ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of NKGen Biotech's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

NKGen Biotech (NKGen Biotech) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NKGen Biotech Inc (NAS:NKGN) » Definitions » ROE % Adjusted to Book Value
Comparable Companies
OCUP CASI SPRO XLO NGM GBIO ASMB CCCC OCEA FIXX OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
19700 Fairchild Road, Suite No. 300, Irvine, CA, USA, 92612
Website
https://www.nkgenbiotech.com
NKGen Biotech Inc is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer cell therapies utilizing our proprietary SNK (super-activated) platform.